PARP inhibitor niraparib as a radiosensitizer promotes antitumor immunity of radiotherapy in EGFR-mutated non-small cell lung cancer
N. Zhang, Yanping Gao, Zihang Zeng, Yanyan Luo, Xupin Jiang, J Zhang, Jing Li, Jing Zhang, Yan Gong, Conghua Xie
Topics & Concepts
MedicineRadiosensitizerCancer researchRadiation therapyOncologyPARP inhibitorLung cancerInternal medicinePoly ADP ribose polymerasePolymeraseChemistryBiochemistryGenePARP inhibition in cancer therapyinterferon and immune responsesCancer Immunotherapy and Biomarkers